Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M49.9Revenue (TTM) $M6.2Net Margin (%)-12.4Altman Z-Score3.5
Enterprise Value $M50.1EPS (TTM) $-0.0Operating Margin %-8.9Piotroski F-Score5
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)-12.4Higher ROA y-yN
Price/Book9.610-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales8.15-y EBITDA Growth Rate %--Current Ratio1.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-66.7ROA % (ttm)-6.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-16.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M66.8ROIC % (ttm)-12.5Gross Margin Increase y-yY

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

IGXT is held by these investors:

IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-11-30Sell25,000$0.750view
Durham John EdwardVP Manufacturing 2016-10-07Buy3,000$0.76-1.32view
Durham John EdwardVP Manufacturing 2016-09-21Buy10,000$0.83-9.64view
Godin AndreEVP & CFO 2016-09-14Buy20,000$0.724.17view
Boudreau BernardDirector 2016-01-22Buy65,000$0.4953.06view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.550view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.487.5view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.5244.23view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.5147.06view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.550view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in Luxembo Apr 13 2017 
IntelGenx and RedHill Biopharma Announce Signing of Definitive Agreement for Commercialization of RI Jul 05 2016 
IntelGenx Reports Amendment of Stock Option Plan May 12 2016 
IntelGenx Reports First Quarter 2016 Financial Results May 10 2016 
IntelGenx to Report First Quarter 2016 Financial Results on May 10, 2016 May 05 2016 
IntelGenx and RedHill Biopharma Announce RIZAPORT(TM) Commercialization Term Sheet With Grupo Juste Mar 29 2016 
IntelGenx Announces Development and Commercialization Term Sheet with a Global Pharmaceutical Compan Mar 24 2016 
IntelGenx to Host Conference Call and Webcast of Fourth Quarter and Full-Year 2015 Financial Results Mar 09 2016 
IntelGenx Appoints Dr. Dana Matzen as Vice President, Business Development Mar 02 2016 
IntelGenx Announces USPTO Has Granted Patent Protecting RIZAPORT(TM) Oral Film for Migraines Feb 18 2016 

More From Other Websites
No related articles found.

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat